Le Lézard
Classified in: Tourism and vacations, Health
Subjects: TDS, FVT

EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE


IRVINE, Calif., May 23, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the Bernstein 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022. 

 Michael A. Mussallem, chairman and chief executive officer, is scheduled to speak to conference attendees at 1:30 p.m. ET.  A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com/.  An archived version of the webcast will be available later that day on the Edwards' investor relations website.

About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.  We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.  For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.  All other trademarks are the property of their respective owners.

 

SOURCE Edwards Lifesciences Corporation


These press releases may also interest you

at 18:00
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plustm, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent to Attend Planet MicroCap Showcase
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
Honoring Audrey Beverly Christy Mastroianni at United Breast Cancer Foundation's Mattress and Pink Bag Event: "Gifts of Comfort and Hope" in Warwick, Rhode Island
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

at 17:31
DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...

at 17:31
Global Corneal Implant Market is Expected to Showcase a Significant Growth at a CAGR of ~6% by 2030 | DelveInsight
DelveInsight's Corneal Implant Market...

at 17:26
Inception Fertilitytm & The Prelude Network® Tell Aspiring Parents 'We Get You, So We Got You' to Humanize the Fertility Experience
In observance of National Infertility Awareness Week (April 21-27, 2024), Inception Fertilitytm, a global leader of fertility services, and The Prelude Network®, Inception's clinical network and the largest network of fertility providers in North...

More news about Health...


News published on and distributed by: